HIV, HBV, HDV, Influenza, RSV, emerging pathogen assays

HIV, HBV, HDV, Influenza, RSV & Emerging Pathogen Assays

Accelevir provides specialized molecular and immunology assay platforms for HIV, HBV, HDV, influenza, RSV, and other emerging pathogens.

• High-Sensitivity Molecular Assays – Digital PCR, qPCR, and NGS-based workflows for viral genome detection and quantification.
• Immune Monitoring – ELISpot, ICS, cytokine multiplex, and multiparameter flow cytometry for pathogen-specific immune responses.
• Multi-Species Capability – Validated assays for mouse, NHP, and human samples to support translational research.
• BSL-2+ Containment – Safe processing of infectious clinical and preclinical samples.
• Emerging Pathogen Readiness – Rapid assay deployment for outbreak and pandemic-response programs.